DexCom, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2521311074
USD
65.25
0.8 (1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
DexCom, Inc.
Abbott Laboratories
Intuitive Surgical, Inc.
Medtronic Plc
Edwards Lifesciences Corp.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Stryker Corp.
IDEXX Laboratories, Inc.
Danaher Corp.
Becton, Dickinson & Co.
Why is DexCom, Inc. ?
1
High Management Efficiency with a high ROE of 20.44%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 20.17% and Operating profit at 21.56%
  • OPERATING CASH FLOW(Y) Highest at USD 987.7 MM
  • INTEREST COVERAGE RATIO(Q) Highest at 5,863.83
  • NET SALES(Q) Highest at USD 1,157.1 MM
4
With ROCE of 31.15%, it has a very expensive valuation with a 16.65 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -20.74%, its profits have fallen by -16.3%
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to DexCom, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is DexCom, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
DexCom, Inc.
-19.35%
-1.03
45.59%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
20.17%
EBIT Growth (5y)
21.56%
EBIT to Interest (avg)
18.63
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.79
Tax Ratio
26.77%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
28.12%
ROE (avg)
20.44%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
64
Industry P/E
Price to Book Value
15.03
EV to EBIT
53.47
EV to EBITDA
39.43
EV to Capital Employed
16.65
EV to Sales
8.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
31.15%
ROE (Latest)
23.61%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 987.7 MM

INTEREST COVERAGE RATIO(Q)

Highest at 5,863.83

NET SALES(Q)

Highest at USD 1,157.1 MM

OPERATING PROFIT(Q)

Highest at USD 275.6 MM

OPERATING PROFIT MARGIN(Q)

Highest at 23.82 %

PRE-TAX PROFIT(Q)

Highest at USD 241.1 MM

NET PROFIT(Q)

Highest at USD 179.8 MM

EPS(Q)

Highest at USD 0.45

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 3.62 times

Here's what is working for DexCom, Inc.
Operating Cash Flow
Highest at USD 987.7 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Interest Coverage Ratio
Highest at 5,863.83
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
Highest at USD 1,157.1 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 275.6 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 23.82 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 241.1 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 179.8 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.45
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Depreciation
Highest at USD 63 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for DexCom, Inc.
Debtors Turnover Ratio
Lowest at 3.62 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio